CMN-009

N/A

Report date: 2023/08/30 16:47:23

Base Information

Drug NameCMN-009
Drug Alias NameCMN-009
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionDelta-like protein 3 modulatorsT lymphocytes stimulantsImmunostimulants
TargetsDelta-like protein 3
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoImmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoImmune Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A